alexa Prognostic Evaluation of Cerebral Venous Sinus Thrombosis Using Clinical and Mr Sequences | OMICS International
ISSN: 2155-9562
Journal of Neurology & Neurophysiology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Prognostic Evaluation of Cerebral Venous Sinus Thrombosis Using Clinical and Mr Sequences

Suvendu Mohapatra*, Basant Manjari Swain and Jayashree Mohanty

Department of Radiology S.C.B Medical College, Cuttack, Odisha, India

Corresponding Author:
Dr Suvendu kumar Mohapatra M.D
Department of Radiology
S.C.B Medical College & Hospital
Cuttack, Odisha, 753007, India
Tel: +09861412800
Fax: +916742390674
E-mail: [email protected]

Received date: April 22, 2014; Accepted dat: August 12, 2014; Published date: August 17, 2014

Citation: Mohapatra S, Swain BM, Mohanty J (2014) Prognostic Evaluation of Cerebral Venous Sinus Thrombosis Using Clinical and Mr Sequences. J Neurol Neurophysiol 5:218. doi:10.4172/2155-9562-5-1000218

Copyright: © 2014 Mohapatra S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Neurology & Neurophysiology

Abstract

Due to diverse clinical presentation of cerebral venous thrombosis it is often under diagnosed in clinical scenarios
first diagnosed by radiologist. Present study is targeted to identify etiology, risk factors, clinical presentation,
radiological findings and its prognostic importance in patients with cerebral venous thrombosis (CVT).
Materials and methods: Patients age ranging from 14 to 68 years with clinical suspicion of cerebral venous
thrombosis was subjected to CT, MRI scan. Patients with positive radiological findings are followed upto 8 weeks.
Results: in our study we have concluded that;
1. CVT incidence is not uncommon in males,
2. Though puerperium is a high risk factor for cerebral venous thrombosis, it is not always associated with poor
outcome.
3. Presence of altered sensorium and focal neurological deficits at admission predicts poor outcome.
4. CT is a good first line investigation for CVT,
5. Features predictive of poor clinical outcome are Presence of parenchymal hypodense lesions in CT, deep
parenchymal T2 hyperintense lesion, restriction of diffusion. Presence of altered sensorium and focal neurological
deficit at admission.

Keywords

Cerebral venous thrombosis; Prognostic; Magnetic resonance imaging; Diffusion weighted imaging

Introduction

Etiology

The cerebral venous system consists of dural venous sinuses, superficial cortical veins, deep medullary and subependymal veins [1]. Cerebral veins contain about 70% of the total cerebral blood volume but CVT occurs about thousand times less often than arterial stroke. Arterial and venous stroke cause different neurological deficits and occur in people of different ages. About half of the patients with an arterial stroke are older than 75 years, whereas CVT most often affects young adults and children. Any pathology that alters the Virchow's triads of flow vessel wall and fluid blood physiology can cause thrombosis [2]. Stroke in young adults accounts 30% of all cases. Among this 10% to 20% are due to CVT [3]. Thrombosis of the cerebral veins may cause focal deficits due to local effects of venous obstruction but also more generalized effects as a result of increased cerebrospinal fluid pressure caused by blocking of the major sinuses. In the majority of patients these two processes occur simultaneously. The course and clinical features of CVT are highly variable. The various causes [4] are Idiopathic, Pregnancy and Puerperium, mastoiditis, dehydration, Oral Contraceptive Pills, Local tumor extension, Trauma, Coagulopathies-Antiphospholipid syndrome, Antithrombin III deficiency, Factor V Leiden mutation, Protein C/S deficiency, PNH, Inflammatory bowel disease.

Clinical features

CVT is protean in its presentation making it very difficult to diagnose unless a high degree of suspicion is present. The presentation can be acute subacute, or chronic. The various signs and symptoms at presentation are [5]. Headache-Most common, present in >80% of cases. Seizures-Present in 35%- 40% of cases. It can be focal or generalized. Focal neurological signs-30%-35%. Altered sensorium-30% Vomitting.

The signs and symptoms of CVT may mimic arterial stroke, intracranial tumors, intracranial infection, subarachnoid hemorrhage or psychiatric disorders. The mortality rate ranges from 10% to 15%. The mortality is usually in the acute stage. The cause being involvement of brainstem, deep parenchyma, transtentorial herniation due to mass effect. The residual deficit rate lies between 6% to 20%. The focal neurological deficits at admission may or may not be reversible. Simple edema and venous congestion, compression due to mass effect may reverse with treatment. Venous infarcts parenchymal hematoma and secondary ischemic necrosis results in permanent neuronal damage and deficits. Depending on the region of brain involvement the deficits can be hemiparesis, monoparesis, paraparesis, blindness, cranial nerve palsy or dysphasia.

Diagnosis

Venous thrombosis has a nonspecific presentation and therefore it is important to recognize subtle imaging findings and indirect signs that may indicate the presence of thrombosis as CVT mostly unsuspected by clinician’s radiological diagnosis remains an important part in its management.

The various modes of investigations are 1.CT scan .2.MRI.3.Catheter Angiogram. 4. Transcranial Doppler 5.biochemical

Computed tomography

The first investigation to be undergone by a patient with CNS signs and symptoms is CT. CT helps in diagnosing > 80%. CT plays an important role in ruling out intracranial abscess or tumors. The various signs of CVT in CT are: Hyperdense triangle sign-Cord sign, Empty Delta sign, Parenchymal hemorrhage, Parenchymal hypodensity. False positive empty delta sign is seen in high splitting tentorium, subdural hematoma, subdural empyema. Recently using MDCT venogram of intracranial venous system can be acquired [4].

Catheter angiogram

The thrombosed sinus appears as empty channel devoid of contrast surrounded by collaterals. Thrombosed cortical veins are seen as intraluminal filling defects and in delayed phase as cord of contrast collection. Since CT and MRI are sensitive and specific in CVT need of catheter angiogram is obviated [6].

MRI

T1WI, T2WI, FLAIR, T2*WI MRV and DWI are used in diagnosis of sinus thrombosis and the parenchymal changes. 2D TOF MRA technique is used for venogram of cerebral sinuses. The thrombus within the sinus can be imaged with T1 and T2 weighted images or with MRV. In T1 and T2 weighted images the normal venous sinus shows flow void due to moving blood. In thrombosed sinuses the flow void is absent with varying signal depending on the age of thrombus and the sequences used. Absent signal with frayed appearance is a feature of thrombosis. Hypoplastic venous sinus, in plane effect, slow flow is some artefactual conditions for false positive finding. The parenchymal edema appears hyperintense in T2WI and FLAIR images. Venous infarcts appear hyperintense in T2 WI and FLAIR images. It is differentiated from edema by DWI which shows hyperintense regions. Hemorrhage can be intraparenchymal or in subarachnoid space. Intraparenchymal hemorrhage appearance in T1 and T2 images vary with the stage of hemoglobin breakdown. FLAIR sequence is highly sensitive for subarachnoid hemorrhage [7].

Transcranial Doppler

Ultrasound techniques may have a role in diagnosing CVT [8].

Biochemical investigations

Quantitative analysis of D- dimer in blood is done. This is a breakdown product of the thrombus. A measurement of >500 ng/ml is highly suggestive of CVT. It has a sensitivity of 83% and specificity of 90% [9]. It is a useful screening modality.

Treatment

The management of CVT consists of symptomatic treatment and definitive treatment of the thrombus. It consists of antiepileptics, treatment of raised intracranial hypertension, antithrombotics, treatment of primary cause, recanalisation of thrombotic veins.

Seizure is a poor prognostic factor. It results in secondary ischemia and brain damage. So control of seizures using antiepileptics both oral and parenteral remain one of the mainstay in CVT treatment.

CVT results in venous congestion, edema, hemorrhage and infarcts. These results in raised ICT. This can result in transtentorial herniation of brain parenchyma and brainstem compression leading to sudden death. So prompt treatment of raised ICT prevents much of the mortality associated with CVT. Treatment consists of medical and surgical methods. Medical management includes IV mannitol. Surgical treatment includes burrhole decompression of cranium, hemicraniectomy, surgical debridement [10].

Heparin remains the firstline treatment of CVT [11] Recent studies show its safety even in hemorrhagic lesions. It is followed by oral anticoagulants for atleast 12 months.

Local thrombolysis is reserved for those who donot respond well to the above treatment. Local urokinase infusion into the thrombosed sinus results in lysis of thrombus. Complication include increased intracranial bleed and pelvic bleed from the puncture site.

Aims and objectives

A comprehensive study was conducted to identify the significance of various etiology, risk factors, clinical presentation, radiological findings and its prognostic importance in patients with cerebral venous thrombosis (CVT).

Materials and methods

Out study is a prospective cohort study of 36 patients age ranging from 14 to 68 carried out at Department of Radiology, S.C.B Medical College, Cuttack between 2009-2011. All the 36 patients were subjected to CT scan and MRI. MRI was performed using GE Signa HDX MR machine with a 1.5 tesla field strength magnet. For MR venogram 2D TOF protocol was used Precontrast images were taken followed by postcontrast images with intravenous administration of 0.1 mmol/kg of body weight of gadolinium. The standard imaging protocol was used.

Study design and statistical method

It was a Prospective cohort study. Null hypothesis testing was done by students t-test using SPSS software 2010 version.

Study population and Sample size:

36 patients with radiologically proven CVT were taken into study and were followed upto 8 weeks.

Inclusion and exclusion Criteria

All patients confirmed by MRI and MRV as cerebral venous sinus thrombosis. Both Males and females are included. All age groups included. Patients with MR incompatible devices or implants. Patients on life support systems. Patients with claustrophobia.

Study method

The clinical features at admission were analysed concentrating on.

Clinical signs: Headache, Seizure, Focal or generalized, Altered sensorium, coma,Focal neurological deficit-Hemiparesis, paraparesis, monoparesis, Cranial nerve palsy, blindness, dysphasia. CT scan findings: presence of hyperdense cord sign, parenchymal haematoma, parenchymal hypodensity. MRI Findings: Hemorrhage, Thrombosis within Sinuses. T2 hyperintense lesion in superficial and deep cerebral regions. Diffusion Restriction-Using DWIs and ADC map.

Results

In this study done in Dept of Radiology S.C.B Medical College, between September 2009 to dec 2011, 36 patients were included. All these patients were selected with clinical features suggestive of cerebral venous thrombosis with MR evidence of cerebral venous sinus thrombosis.

The age range of the affected patients is 14 to 68 with a mean age of 41. There is no statistically significant association of age with poor outcome in our study as against the study of Stolz, Rahimi et al. [12] who showed increasing age to be a poor prognostic indicator. The Male: Female sex ratio in this study is 1:1.57 that is, males form 38% of the patients. This shows that CVT is not uncommon among males and should be a differential diagnosis in any patient with suspicious CNS signs and symptoms. Sex does not play a significant role in outcome of CVT in this study.

In a study by José M. Ferro et al. [13] showed male sex to be a poor prognostic factor for CVT.

Among the 22 female patients 15 were in puerperal period that is 68% of the female patients. This proves that puerperium is high risk for CVT but the outcome among puerperal females does not show any significant difference from the nonpregnant female p value >0.05. High incidence in peurperium corresponding with C Cantu and F Barinagarrementeria et al. [14] which also showed high incidence in same group.In the study of Appenzeller et al. [5] pregnancy and puerperium, were good prognostic indicators.but in this study peurperium is not a very prognostic factor may be due to delayed time of diagnosis and late treatment.

In this study the percentage of presenting symptoms are Headache-77% Seizure-25%, Altered Sensorium-33% Neurological Deficit-17%. Among these presenting symptoms, altered sensorium and focal neurologic deficit are statistically significant poor prognostic indicators at 8 weeks follow up.

This is in agreement with the study of Appenzeller et al. [5] and Ferro, Canhao et al. [15]

The number of patients with parenchymal hemorrhage detected by CT is 9, out of which 3 had poor outcome as per table nos.8. It is found that this sign is not a poor prognostic indicator with P>0.05.

According to Ferro, Canhao et al. [15] hemorrhage on admission CT is associated with poor outcome.

The incidence of thrombosis in CT are Superior Sagittal Sinus-75%, Lateral Sinus-36%, Straight Sinus-11%. There is no significant association of thrombosis with the patient outcome.

The presence of parenchymal hypodensity in CT which can be either simple vasogenic edema or a venous infarct was found to be in 7 patients (19.6%) of which 3 died and 3 had deficit. This has a highly significant association with poor outcome with P<0.001.

41.6% of patients had intraparenchymal hemorrhage detected by MRI. 4 patients out of this had poor outcome. That is 4 out of the 8 poor outcome group had hemorrhage. This is not a statistically significant association.

The presence of thrombosis detected by MRI are Superior Sagital Sinus-89% Lateral Sinus-75%, Straight Sinus-20%.This corresponded with similar statistics in literature.

The presence of thrombosis in superior sagittal sinus, lateral sinus and straight sinus is not associated with poor outcome. Ferro Canhao et al. [15] predicted a poor outcome with deep cerebral venous thrombosis. Deep Cerebral venous thrombosis is associated with thalamic and deep grey matter and brainstem lesion. So it is associated frequently with altered sensorium and poor Glascow coma scale. This explains the poor outcome of patients with deep cerebral venous thrombosis.

Straight sinus thrombosis is seen in 4 patients in CT whereas in MRI in 7 patients showing the greater pickup rate in MRI.

Detection of deep T2 hyperintense lesions has a poor outcome. In our study 8 out of 36 had deep T2 hyperintense lesions. Out of this 8 patients 7 (87.8%) had poor outcome. In our study of the 8 poor outcome patients 7 (87.8%) had deep T2 hyperintense lesions. So deep hyperintense lesion are sensitive and specific in predicting poor outcome with p<0.001 showing a strong association. In a study by Imada et al. [16] which shows similar association.

Edema can be vasogenic or cytotoxic edema. Cytotoxic edema is due to entry of water into the cells due to decreased ATP. This in course leads to cell death and infarction. So cytotoxic edema is the precursor of infarction. Since intracellular macromolecules and membranous organelles interact and bound with the intracellular water molecules, these protons have restricted diffusion. This can be detected by using DWI in which separate diffusion gradients of varying strengths are given and the signal loss due to diffusion is measured. In DWI free protons have decreased signals in higher gradients, whereas bound or restricted protons give higher signals or hyperintense. It is to be remembered that cytotoxic edema is only the precursor of infarction. In our study group all the 8 patients who had poor outcome had restricted diffusion.

In other words all poor outcome patients had diffusion restriction i.e 100% sensitive in predicting outcome. But none of the patients who had restricted diffusion recovered completely. According to Mullins et al. [17] three out of 14 lesions had restricted diffusion but resolved in follow-up and 4 out of 14 had restricted diffusion and persisted. In our study against the above study 8 out of 10 had restricted diffusion and had poor out come and none out of 10 had restricted diffusion and with good outcome. Reversibility of DWI restricted lesions are shown in the studies of Appenhium et al. [18], Farbe et al. [19].

Conclusion

In our study of conclusions can be summarised as follows. High degree of clinical suspicion required for diagnosis of CVT because of its varied nonspecific clinical features. CVT incidence is not uncommon in males. Though puerperium is a high risk factor for cerebral venous thrombosis, it is not always associated with poor outcome. Presence of altered sensorium and focal neurological deficits at admission predicts poor outcome. CT is a good first line investigation for Cerebral venous thrombosis. Presence of parenchymal hypodense lesions in CT is associated with poor outcome and MRI features predictive of poor outcome are deep parenchymal T2 hyper intense lesion and restriction of diffusion.

Figure

Figure 1: 3D TOF MR Venogram Showing Hypoplastic Left Lateral Sinus

Figure

Figure 2: MRI Axial T2 Image Showing Bithalamic Hyperintensity (INFARCT)

Figure

Figure 3: MRI Sagital T1 Showing Superior Sagital Sinus Thrombosis

Figure

Figure 4: CECT Image Showing Empty Delta Sign

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11778
  • [From(publication date):
    August-2014 - Dec 17, 2017]
  • Breakdown by view type
  • HTML page views : 7989
  • PDF downloads : 3789
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version